Treatment and Care

This report provides statistics on annual hospitalizations estimated from hospital discharges during 1997–2007 with any listed HIV/AIDS diagnoses. From 1997-2007 a substantially higher rate of men than women aged greater than or equal to 45 years were hospitalized with a diagnosis of HIV/AIDS. Hospitalization rates for men in this age group increased from 7.7 per 10,000 in 1997 to 14.8 in 2007; rates for women in this age group increased from 1.9 per 10,000 in 1997 to 4.9 in 2007.

This information sheet discusses the viral infections Hepatitis A, Hepatitis B, and Hepatitis C, which cause liver disease. It describes the modes of transmission for each, the epidemiology of these diseases in the United States, the difference between acute and chronic disease as well as the symptoms, methods of diagnosis, and treatment. The information sheet explains the high risk of these diseases among gay and bisexual men and notes that experts recommend that gay and bisexual men should be tested for Hepatitis B and should be vaccinated for Hepatitis A and B.

This information sheet discusses hepatitis B, a contagious liver disease caused by infection with the hepatitis B virus. It explains the difference between acute infection and chronic disease. It describes Hepatitis B transmission, whether the disease is common, its symptoms, how it is diagnosed, the seriousness of the disease, the importance of being tested for Hepatitis B and who should be tested, treatment, how persons with hepatitis B can take care of their liver, and how the disease can be prevented by getting vaccinated.

This information sheet discusses chronic hepatitis B, a contagious liver disease that results from infection with the hepatitis B virus (HBV). It explains the difference between acute and chronic infection and how likely HBV is to become a chronic infection, the seriousness of chronic hepatitis B, its transmission and symptoms, how it is diagnosed, the importance of getting tested, and who should be tested.

This information sheet discusses chronic hepatitis B, a contagious liver disease that results from infection with the hepatitis B virus (HBV). It explains the difference between acute and chronic infection and how likely Hepatitis B is to become a chronic infection, the seriousness of chronic Hepatitis B, its transmission and symptoms, how it is diagnosed, the importance of getting tested, and who should be tested.

This internet file provides an algorithm for the management and treatment of hepatitis C. It is based on a critical review of available data and expert consensus.

This information sheet provides general information about hepatitis C. It explains that hepatitis is an inflammation of the liver, and hepatitis C is a contagious liver disease caused by a virus. The information sheet discusses the effect of hepatitis C on the liver, the acute and chronic forms of the disease, hepatitis C transmission, its epidemiology, the seriousness of the disease, its symptoms, diagnostic tests that are used, who should be tested, the treatment, and how people with hepatitis C can take care of their liver.

This information sheet provides general information about hepatitis B. It explains the disease; provides statistics on hepatitis B in the United States; and discusses at-risk persons, transmission, symptoms, diagnosis, and treatment of Hepatitis B. It promotes vaccine as the best method of preventing the disease and lists persons who should get vaccinated against hepatitis B.

This information sheet provides general information about hepatitis B. It explains the disease; provides statistics on hepatitis B in the United States; and discusses at-risk persons, transmission, symptoms, diagnosis, and treatment of Hepatitis B. It promotes vaccine as the best method of preventing the disease and lists persons who should get vaccinated against hepatitis B.

This is a planning document designed to facilitate the integration of strong public-private mix components into national TB strategic plans that are supposed to be the basis for Global Fund proposals and national budgeting processes, and will help drive a more comprehensive approach to provider engagement in TB care and prevention.